CD38-NAD+ regulated metabolic axis in anti-tumor immunotherapy Grant US-11883430-B2 United States of America 30 Jan 2024
CD38-NAD+ REGULATED METABOLIC AXIS IN ANTI-TUMOR IMMUNOTHERAPY Application EP-3538112-A4 European Patent Office 02 Sep 2020
Regulatory T-cells for use in the treatment of inflammatory disorders of the human… Grant US-10758568-B2 United States of America 01 Sep 2020
CD38-NAD+ REGULATED METABOLIC AXIS IN ANTI-TUMOR IMMUNOTHERAPY Application WO-2018089423-A1 World Intellectual Property Organisation (WIPO) 17 May 2018